Reasons for reporting adverse drug reactions - Some thoughts based on an international review

Pharmacoepidemiology and Drug Safety

Volumn 6, Issue 1, 1997, Pages 21-26

  Biriell, Cecilia ^a   Edwards, I Ralph ^a  

^a WHO Collaborating Ctr Intl Drug M   (Sweden)

Author keywords

adverse drug reaction reporting; pharmacovigilance

Indexed keywords

ADVERSE DRUG REACTION; ARTICLE; DRUG INFORMATION; DRUG MONITORING; HUMAN; PHARMACIST; PHYSICIAN; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 0030896727     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199701)6:1<21::AID-PDS259>3.0.CO;2-I     Document Type: Article

References (6)

1. Inman, W. H. W. Detection and investigation of drug safety problems. In: Epidemiological Issues in Reported Drug-Induced Illnesses, Honolulu 1976. Gent, M. and Shigamatsu, I. (Eds) McMaster University Library Press, Hamilton, Ontario, 1978.
2. Koch-Weser, J., Sidel, V. W., Sweet, R. H., Kanarek, P. and Eaton, A. E. Factors determining physician reporting of adverse drug reactions. Comparison of 2000 spontaneous reports with surveillance studies at the Massachusetts General Hospital. New England Journal of Medicine 1969; 280(1): 20-26.
3. Rogers, A. S., Israel, E., Smith, C. R., et al. Physician knowledge, attitudes and behaviour related to reporting adverse drug events. Archives of Internal Medicine 1988; 148: 1596-1600.
4. Bateman, D. N., Sanders, G. L. and Rawlins, M. D. Attitudes to adverse drug reaction reporting in the Northern Region. British Journal of Clinical Pharmacology. 1992; 34: 421-426.
5. Belton, K. J., Lewis, S. C., Payne, S. and Rawlins, M. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. British Journal of Clinical Pharmacology 1995; 39: 223-226.
6. Lindquist, M. and Edwards, I. R. Adverse drug reaction reporting in Europe: some problems of comparison. International Journal of Risk and Safety in Medicine 1993; 4: 35-46.